01 1Cambrex Corporation
01 1MIDAZOLAM
01 1U.S.A
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2014-04-18
Pay. Date : 2014-04-10
DMF Number : 12686
Submission : 1997-10-06
Status : Active
Type : II
20
Cambrex Profarmaco Milano Srl, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for Cambrex is an innovative life sciences company with a refreshingly human approach.
One of their notable products is MIDAZOLAM, with a corresponding US DMF Number 12686.
Remarkably, this DMF maintains an Active status since its submission on October 06, 1997, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of April 18, 2014, and payment made on April 10, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II
